Latest News
January 29, 2009 — Symphogen Acquires Receptor BioLogix's Technology
October 28, 2008 — Receptor BioLogix Names Veteran Life Sciences Executive Dale R. Pfost As Chief Executive Officer
October 28, 2008 — Newly Published Preclinical Study Shows Receptor BioLogix's Pan-HER Ligand Trap Has Broad Anti-Cancer Activity